Peptide Clinical Trials intermediate
Degarelix - CS21 (NCT00106437)
Comprehensive reference for Degarelix - CS21 (NCT00106437), a peptide compound with applications in research and therapeutics.
By Encyclopeptide Editorial | 1 min read
peptide-clinical-trials peptide oligopeptide
Overview
Degarelix - CS21 (NCT00106437) is a peptide compound with applications in research and therapeutics.
Structure
Degarelix - CS21 (NCT00106437) belongs to the Peptide Clinical Trials class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.
Applications
Degarelix - CS21 (NCT00106437) has been studied for its potential applications in:
- Biomedical research
- Drug discovery
- Diagnostic applications
- Therapeutic development
References
- Source: peptide-clinical-trials.md
- Database: Wikipept Peptide Database
Test Your Knowledge
Reinforce what you learned about Degarelix - CS21 (NCT00106437) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept